Vita34 ApS: Financial statements 2022
CVR: 27511759
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Vita34 ApS (CVR 27511759) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 7,850,419 and a net result of DKK 5,146,487 compared with DKK 2,725,955 the year before. That is an increase of 50% compared with the year before. Equity in the 2022 report amounted to DKK 1,867,211. The solvency ratio was 8.8%.
- Gross Profit
- DKK 7,850,419
- Profit/Loss
- DKK 5,146,487
- Equity
- DKK 1,867,211
- Total Assets
- DKK 21,279,524
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 7.9M | 5.1M | 1.9M | 0 |
| 2021 | - | 5.2M | 2.7M | -3.3M | 0 |
| 2020 | - | 5.2M | 2.6M | -6M | 0 |
| 2019 | - | 2.4M | -231K | -8.6M | 0 |
| 2018 | - | 4.8M | -4M | -8.4M | 12 |
Official annual report
Keep an eye on Vita34 ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Vita34 ApS has published its annual report for 2021. Gross profit came to DKK 5,232,139, and the net result was DKK 2,725,955.
As of June 29, 2022, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Vita34 ApS.
As of June 22, 2022, Georg Maria Steinbacher is registered as director of Vita34 ApS.
As of March 21, 2022, Dr. Wolfgang Johannes Knirsch has stepped down as director of Vita34 ApS.
About Vita34 ApS
Vita34 ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2004. The company is registered under the industry Drift af sundhedsvæsen i øvrigt i.a.n.. The company was previously named StemCare ApS and BIOBANK DANMARK ApS. The management consists of Marion Bartel and Vivien Weise. The company is owned by FamiCord AG. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 3,842,095 and a net result of DKK 1,034,065 compared with DKK 1,030,138 the year before. Equity in the 2025 report amounted to DKK 5,982,880.